The store will not work correctly when cookies are disabled.
1-Phenyl-5-(3-thiophen-2-yl-allylidene)-2-thioxo-dihydropyrimidine-4,6-dione
ID: ALA4167822
PubChem CID: 145953409
Max Phase: Preclinical
Molecular Formula: C17H12N2O2S2
Molecular Weight: 340.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC(=S)N(c2ccccc2)C(=O)/C1=C/C=C/c1cccs1
Standard InChI: InChI=1S/C17H12N2O2S2/c20-15-14(10-4-8-13-9-5-11-23-13)16(21)19(17(22)18-15)12-6-2-1-3-7-12/h1-11H,(H,18,20,22)/b8-4+,14-10+
Standard InChI Key: LRPFABRWUCECRW-QXAPVUDZSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
17.9464 -11.4842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2387 -11.8917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5268 -11.4842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5268 -10.6651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2387 -10.2534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9464 -10.6651 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8190 -11.8917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2387 -9.4385 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6542 -11.8917 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.8190 -10.2534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1112 -10.6651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4034 -10.2534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6915 -10.6651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6064 -11.4778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8087 -11.6509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3971 -10.9390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9447 -10.3337 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.6542 -10.2534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6542 -9.4385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3620 -9.0268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0739 -9.4385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0739 -10.2534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3620 -10.6651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
3 7 2 0
5 8 2 0
1 9 2 0
10 11 1 0
11 12 2 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
13 17 1 0
12 13 1 0
4 10 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
18 23 2 0
6 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 340.43 | Molecular Weight (Monoisotopic): 340.0340 | AlogP: 3.14 | #Rotatable Bonds: 3 |
Polar Surface Area: 49.41 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.22 | CX Basic pKa: ┄ | CX LogP: 4.00 | CX LogD: 3.60 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.53 | Np Likeness Score: -1.79 |
References
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |